Overview
Availability
- Associate Professor David Wyld is:
- Available for supervision
Works
Search Professor David Wyld’s works on UQ eSpace
2021
Journal Article
Preclinical molecular PET-CT imaging targeting CDCP1 in colorectal cancer
Cuda, Tahleesa J., He, Yaowu, Kryza, Thomas, Khan, Tashbib, Tse, Brian W., Sokolowski, Kamil A., Liu, Cheng, Lyons, Nicholas, Gough, Madeline, Snell, Cameron E., Wyld, David K., Rose, Stephen, Riddell, Andrew D., Stevenson, Andrew R. L., Thomas, Paul A., Clark, David A., Puttick, Simon and Hooper, John D. (2021). Preclinical molecular PET-CT imaging targeting CDCP1 in colorectal cancer. Contrast Media and Molecular Imaging, 2021 3153278, 3153278. doi: 10.1155/2021/3153278
2021
Journal Article
Prospective cohort study of an Australian cancer care services-led model of emergent care
Button, Elise, Gavin, Nicole C., Bates, Tracey, Ahmed, Deka, Nasato, Gillian, Wyld, David, Kennedy, Glen, Fennelly, Eileen, Smith, Michael, Northfield, Sarah and Yates, Patsy (2021). Prospective cohort study of an Australian cancer care services-led model of emergent care. Australian Health Review, 45 (5), 613-621. doi: 10.1071/AH20346
2021
Conference Publication
177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with somatostatin-expressing neuroendocrine tumors: a real-world retrospective review of efficacy and safety from an Australian tertiary cancer Center
Nalder, Mark, Ladwa, Rahul, Raina, Anant, Burge, Matthew E., Love, Amanda, Pattison, David A., Ramsay, Stuart and Wyld, David (2021). 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with somatostatin-expressing neuroendocrine tumors: a real-world retrospective review of efficacy and safety from an Australian tertiary cancer Center. 2021 ASCO Annual Meeting I, Virtual, 4-8 June 2021. Alexandria, VA USA: American Society of Clinical Oncology. doi: 10.1200/jco.2021.39.15_suppl.e16198
2021
Journal Article
Semiqualitative research protocol to explore cancer care workforce perceptions of the health system response to COVID-19 preparations in Southeast Queensland, Australia
Gasper, Harry, Ahern, Elizabeth, Roberts, Natasha, Chan, Bryan, Hughes, Brett, Kennedy, Glen, Wyld, David, Eastgate, Melissa and Lwin, Zarnie (2021). Semiqualitative research protocol to explore cancer care workforce perceptions of the health system response to COVID-19 preparations in Southeast Queensland, Australia. BMJ Open, 11 (5) e044655, e044655. doi: 10.1136/bmjopen-2020-044655
2021
Journal Article
Resilience and ongoing quality care for cancer clinical trials during COVID-19: experience from a tertiary hospital in Australia
Ives, Amy, Pusztai, Tricia, Keller, Jacqui, Ahern, Elizabeth, Chan, Bryan, Gasper, Harry, Wyld, David, Kennedy, Glen, Dickie, Graeme, Lwin, Zarnie and Roberts, Natasha A. (2021). Resilience and ongoing quality care for cancer clinical trials during COVID-19: experience from a tertiary hospital in Australia. Asia-Pacific Journal of Clinical Oncology, 18 (2), e141-e147. doi: 10.1111/ajco.13570
2021
Conference Publication
P3BEP (ANZUP 1302): An international randomized phase III trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumors (GCTs)
Subramaniam, Shalini, Toner, Guy C., Stockler, Martin R., Martin, Andrew James, Pashankar, Farzana D., Tran, Ben, Jeffery, Mark, Mazhar, Danish, Huddart, Robert A., Walpole, Euan Thomas, Stevanovic, Amanda Gwendolyn, Wyld, David, Hanning, Fritha J., Wheater, Matthew James, Balagtas, Jay R., Troon, Simon, Birtle, Alison Jane, White, Jeff D. and Grimison, Peter S. (2021). P3BEP (ANZUP 1302): An international randomized phase III trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumors (GCTs). ASCO Genitourinary Cancers Symposium (GU ASCO), Online, 11-13 February 2021. Alexandria, VA, United States: American Society of Clinical Oncology. doi: 10.1200/JCO.2021.39.6_suppl.TPS390
2021
Journal Article
Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): the NETPET score as a prognostic biomarker
Chan, David L., Ulaner, Gary A., Pattison, David A., Wyld, David, Ladwa, Rahul, Kirchner, Julian, Li, Bob T, Lai, W Victoria, Pavlakis, Nick, Roach, Paul J and Bailey, Dale L (2021). Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): the NETPET score as a prognostic biomarker. Journal of Nuclear Medicine, 62 (9), 1278-1284. doi: 10.2967/jnumed.120.257659
2021
Journal Article
Hemoglobin, body mass index, and age as risk factors for Paclitaxel- and Oxaliplatin-induced peripheral neuropathy
Mizrahi, David, Park, Susanna B., Li, Tiffany, Timmins, Hannah C., Trinh, Terry, Au, Kimberley, Battaglini, Eva, Wyld, David, Henderson, Robert D., Grimison, Peter, Ke, Helen, Geelan-Small, Peter, Marker, Julie, Wall, Brian and Goldstein, David (2021). Hemoglobin, body mass index, and age as risk factors for Paclitaxel- and Oxaliplatin-induced peripheral neuropathy. JAMA Network Open, 4 (2) e2036695, 1-14. doi: 10.1001/jamanetworkopen.2020.36695
2021
Journal Article
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
Kang, Eun Young, Cheasley, Dane, LePage, Cecile, Wakefield, Matthew J., da Cunha Torres, Michelle, Rowley, Simone, Salazar, Carolina, Xing, Zhongyue, Allan, Prue, Bowtell, David D. L., Mes-Masson, Anne-Marie, Provencher, Diane M., Rahimi, Kurosh, Kelemen, Linda E., Fasching, Peter A., Doherty, Jennifer A., Goodman, Marc T., Goode, Ellen L., Deen, Suha, Pharoah, Paul D. P., Brenton, James D., Sieh, Weiva, Mateoiu, Constantina, Sundfeldt, Karin, Cook, Linda S., Le, Nhu D., Anglesio, Michael S., Gilks, C. Blake, Huntsman, David G. ... Campbell, Ian G. (2021). Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses. Modern Pathology, 34 (1), 194-206. doi: 10.1038/s41379-020-0618-9
2021
Journal Article
Incidence, survival and stage at diagnosis of small intestinal neuroendocrine tumours in Queensland, Australia, 2001-2015
Wyld, David, Moore, Julie, Tran, Nancy and Youl, Philippa (2021). Incidence, survival and stage at diagnosis of small intestinal neuroendocrine tumours in Queensland, Australia, 2001-2015. Asia-Pacific Journal of Clinical Oncology, 17 (4), 350-358. doi: 10.1111/ajco.13503
2020
Journal Article
PET imaging quantifying Ga-PSMA-11 uptake in metastatic colorectal cancer
Cuda, Tahleesa J., Riddell, Andrew D., Liu, Cheng, Whitehall, Vicki L., Borowsky, Jennifer, Wyld, David K., Burge, Matthew E., Ahern, Elizabeth, Griffin, Alison, Lyons, Nicholas J. R., Rose, Stephen E., Clark, David A., Stevenson, Andrew R. L., Hooper, John D., Puttick, Simon and Thomas, Paul A. (2020). PET imaging quantifying Ga-PSMA-11 uptake in metastatic colorectal cancer. The Journal of Nuclear Medicine, 61 (11), 1576-1579. doi: 10.2967/jnumed.119.233312
2020
Journal Article
Statistical Process Control assessed implementation fidelity of Patient Reported Outcome Measures (PROMs) in routine care
Roberts, Natasha A., Alexander, Kimberly, Wyld, David and Janda, Monika (2020). Statistical Process Control assessed implementation fidelity of Patient Reported Outcome Measures (PROMs) in routine care. Journal of Clinical Epidemiology, 127, 76-86. doi: 10.1016/j.jclinepi.2020.06.022
2020
Conference Publication
Haemoglobin, body mass index and age as risk-factors for paclitaxel- and oxaliplatin-induced peripheral neuropathy
Mizrahi, D., Park, S. B., Li, T., Timmins, H., Trinh, T., Au, K., Battaglini, E., Wyld, D., Henderson, R., Grimison, P., Ke, H., Marker, J., Wall, B. and Goldstein, D. (2020). Haemoglobin, body mass index and age as risk-factors for paclitaxel- and oxaliplatin-induced peripheral neuropathy. ESMO Asia Virtual Congress, Electr Network, Nov 20-22, 2020. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2020.10.328
2020
Journal Article
The utility of the implementation science framework “Integrated Promoting Action on Research Implementation in Health Services” (i-PARIHS) and the facilitator role for introducing patient-reported outcome measures (PROMs) in a medical oncology outpatient department
Roberts, Natasha A., Janda, Monika, Stover, Angela M., Alexander, Kimberly E., Wyld, David and Mudge, Alison (2020). The utility of the implementation science framework “Integrated Promoting Action on Research Implementation in Health Services” (i-PARIHS) and the facilitator role for introducing patient-reported outcome measures (PROMs) in a medical oncology outpatient department. Quality of Life Research, 30 (11), 3063-3071. doi: 10.1007/s11136-020-02669-1
2020
Conference Publication
Emotional impact of COVID-19 preparations on metro and regional cancer workforces in Queensland Australia: "We are all in this together"
Roberts, Natasha Anne, Chan, Bryan, Ahern, Elizabeth Stephanie, Gasper, Harry Michael, Kennedy, Glen, Hughes, Brett Gordon Maxwell, Wyld, David, Eastgate, Melissa A. and Lwin, Zarnie (2020). Emotional impact of COVID-19 preparations on metro and regional cancer workforces in Queensland Australia: "We are all in this together". 2020 ASCO Quality Care Symposium, Chicago, IL USA, 9-10 October 2020. Alexandria, VA USA: American Society of Clinical Oncology. doi: 10.1200/jco.2020.38.29_suppl.44
2020
Conference Publication
Psychosocial impacts of COVID-19 on oncology workforces: metro versus regional Australia
Ahern, Elizabeth Stephanie, Gasper, Harry Michael, Chan, Bryan, Roberts, Natasha Anne, Hughes, Brett Gordon Maxwell, Wyld, David, Kennedy, Glen, Eastgate, Melissa A. and Lwin, Zarnie (2020). Psychosocial impacts of COVID-19 on oncology workforces: metro versus regional Australia. 2020 ASCO Quality Care Symposium, Chicago, IL USA, 9-10 October 2020. Alexandria, VA USA: American Society of Clinical Oncology. doi: 10.1200/jco.2020.38.29_suppl.111
2020
Journal Article
Determining the CA19-9 concentration that best predicts the presence of CT-occult unresectable features in patients with pancreatic cancer: a population-based analysis
McGahan, William, Waterhouse, Mary A., O'Connell, Dianne L., Merrett, Neil D., Goldstein, David, Wyld, David, Burmeister, Elizabeth A., Jordan, Susan J. and Neale, Rachel E. (2020). Determining the CA19-9 concentration that best predicts the presence of CT-occult unresectable features in patients with pancreatic cancer: a population-based analysis. Pancreatology, 20 (7), 1458-1464. doi: 10.1016/j.pan.2020.07.405
2020
Journal Article
Trends in epidemiology, treatment and molecular testing of metastatic colorectal cancer in a real‐world multi‐institution cohort study
Kuchel, Anna, Ahern, Elizabeth, Collins, Stephanie, Whitehall, Vicki, Okano, Satomi, Pelecanos, Anita, Wyld, David, Eastgate, Melissa and Burge, Matthew (2020). Trends in epidemiology, treatment and molecular testing of metastatic colorectal cancer in a real‐world multi‐institution cohort study. Asia-Pacific Journal of Clinical Oncology, 17 (1) ajco.13420, 84-93. doi: 10.1111/ajco.13420
2020
Journal Article
Prognostic gene expression signature for high-grade serous ovarian cancer
Millstein, J., Budden, T., Goode, E.L., Anglesio, M.S., Talhouk, A., Intermaggio, M.P., Leong, H.S., Chen, S., Elatre, W., Gilks, B., Nazeran, T., Volchek, M., Bentley, R.C., Wang, C., Chiu, D.S., Kommoss, S., Leung, S.C.Y., Senz, J., Lum, A., Chow, V., Sudderuddin, H., Mackenzie, R., George, J., Fereday, S., Hendley, J., Traficante, N., Steed, H., Koziak, J.M., Köbel, M. ... AOCS Group (2020). Prognostic gene expression signature for high-grade serous ovarian cancer. Annals of Oncology, 31 (9), 1240-1250. doi: 10.1016/j.annonc.2020.05.019
2020
Journal Article
Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumours
Lim, Lisi Elizabeth, Chan, David L., Thomas, David, Du, Yang, Tincknell, Gary, Kuchel, Anna, Davis, Alexander, Bailey, Dale L., Pavlakis, Nick, Cehic, Gabrielle, Macdonald, William, Wyld, David and Segelov, Eva (2020). Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumours. OncoTarget, 11 (27), 2636-2646. doi: 10.18632/oncotarget.27659
Supervision
Availability
- Associate Professor David Wyld is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Supervision history
Completed supervision
-
2020
Master Philosophy
Predictors of dosimetry and outcome to peptide receptor radionuclide therapy in metastatic neuroendocrine tumour.
Principal Advisor
Other advisors: Professor David Pattison
-
2021
Doctor Philosophy
Targeting receptor activator of NF-kB pathways in combination immunotherapy
Associate Advisor
Media
Enquiries
For media enquiries about Associate Professor David Wyld's areas of expertise, story ideas and help finding experts, contact our Media team: